Perhaps the simplest and most efficient way to measure CD14+HLA-DRlo/neg monocytes is by flow cytometry of peripheral blood; therefore, acquisition of tumor biopsies which may not always be available from patients is unnecessary. The gene discussed is CD14; the disease is neoplasm.